Vector-borne diseases (VBDs), transmitted by vectors such as mosquitoes, ticks, and fleas, are a significant public health concern in India. This article provides a comprehensive analysis of the prevalence and management of VBDs in India, aimed at guiding healthcare professionals in their practice.
India's tropical climate and high population density make it a hotspot for VBDs. Malaria, dengue, and chikungunya are the most prevalent, with malaria accounting for approximately 88% of the Southeast Asia region's cases. Dengue cases have also escalated, with an estimated 100-200 million infections annually. The prevalence of Chikungunya has fluctuated in recent years, but outbreaks continue to occur.
Managing VBDs in India is challenging due to factors like inadequate healthcare infrastructure, lack of public awareness, and climate change. Additionally, the high cost of treatment and diagnosis, coupled with the absence of specific antiviral drugs for diseases like dengue and chikungunya, complicates the situation further.
Strategies to control VBDs in India include vector control, disease surveillance, and community participation. Vector control includes measures like insecticide-treated nets and indoor residual spraying. Disease surveillance involves monitoring and reporting cases to identify outbreaks early. Community participation is crucial for the success of these interventions, emphasizing the importance of health education.
Healthcare professionals play a pivotal role in managing VBDs. They are responsible for early diagnosis, appropriate treatment, and patient education. Furthermore, they can contribute to research, policy-making, and implementation of control strategies.
Vector-borne diseases pose a significant health burden in India. Effective management requires concerted efforts from healthcare professionals, policymakers, and the community. By understanding the prevalence and unique challenges presented by these diseases, professionals can contribute to their control and prevention.
1.
NPM1-Mutated AML: Not All Treatments Are Equal
2.
Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey
3.
MRI can save rectal cancer patients from surgery, study suggests
4.
Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer
5.
Rising rates of head and neck cancers in England
1.
A Closer Look at Breast Cancer: Examining the Ultrasound Images
2.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
3.
Molecular Classification of Refractory Anemia: A Comprehensive Review
4.
Ferroptosis-Modulating Therapeutics in Precision Oncology
5.
Blood-Cell Morphology Foundation Models: Transforming Hematological Diagnostics and Clinical Practice
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World
2.
Thromboprophylaxis In Medical Settings- An Update
3.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
4.
How Platelet Disorders Can Affect the Body
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation